Blog

Follow us for the latest trends, insights and
innovations in the pharmaceutical industry.
Blog banner Empagliflozin Intermediate Sourcing Buyers Guide, SGLT2 inhibitor chiral purity control, acetoxy empagliflozin α-anomer impurity & Jardiance patent procurement tips

Empagliflozin Intermediate Sourcing: Buyers Guide

This buyer's guide maps the Boehringer Ingelheim synthesis route, identifies four commercially critical intermediates with CAS numbers, explains why six chiral centers create six separate ...
Read More →
Blog cover showing pharmaceutical intermediate storage conditions, including hydrolysis, photodegradation and thermal decomposition risks for buyers

Pharmaceutical Intermediate Storage Conditions: What Buyers Must Know

This guide explains three degradation pathways triggered by improper storage (hydrolysis, photodegradation, and thermal decomposition), decodes what "Store at CRT" actually means under USP ...
Read More →
Nitrosamine impurity regulatory storm blog banner, valsartan NDMA contamination risk guide for pharma intermediate buyers following FDA EMA nitrosamine control guidance

Nitrosamine Impurity Risk in Intermediates: Guide

This guide explains three formation pathways (amine + nitrite reaction, recovered solvent contamination, and shared-equipment cross-contamination), walks through the CPCA classification framework for assessing risk ...
Read More →
COA retest date vs expiry date blog banner, ICH stability guideline explanation for pharmaceutical intermediate procurement teams avoiding inventory material waste

Intermediate Retest Date vs Expiry Date: What Buyers Must Know

This guide clarifies the three terms (retest date, expiry date, shelf life) with ICH definitions, explains how manufacturers assign retest periods using a risk-based stability ...
Read More →
Scroll to Top

Contact us to Get the Best Product Solution